Lowering the Threshold of Suspicion: Pharmacist-led Strategies to Improve the Recognition and Management of hATTR Amyloidosis

Lowering the Threshold of Suspicion: Pharmacist-led Strategies to Improve the Recognition and Management of hATTR Amyloidosis

This activity is jointly provided by AKH, Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

ACTIVITY OVERVIEW

Often the first to see patients with manifestations of hATTR amyloidosis, pharmacists are a valuable part of the healthcare team.  This activity will provide pharmacist-specific information that will help these HCPs identify potential patients with hATTR amyloidosis and provide appropriate information on treatment options.

TARGET AUDIENCE

This activity is intended for pharmacists from all inpatient and outpatient practice settings.

LEARNING OBJECTIVES

Upon completion of this activity, the learner should be able to:

  1. Recognize the prevalence, demographics, and disease burden of hATTR amyloidosis
  2. Describe clinical manifestations and specific symptoms that may be attributed to hATTR amyloidosis
  3. Implement pharmacist-driven strategies to effectively and efficiently identify potential patients with hATTR amyloidosis in clinical practice
  4. Assess the efficacy and safety of hATTR amyloidosis treatment options to inform appropriate, individualized treatment and decision-making 

INSTRUCTIONS FOR PARTICIPATION AND CREDIT

Statements of credit will be awarded based on the participant reviewing activity, scoring a 70%or higher on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. There is no fee to participant in this activity. If you have questions about this activity, please contact AKH Inc. at tbrignoni@akhcme.com.

 CE Credit provided by AKH Inc.,
Advancing Knowledge in Healthcare

ACCREDITATION

acpePharmacists
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 1.25 contact hour(s) (0.125 CEUs). UAN 0077-9999-20-023-H04-P.

Activity Release Date: 11/16/2020
Activity Expiration Date: 11/16/2021
1.25 hour activity | ACPE

FACULTY

David Simpson, MD, FAAN (Course Director)
Professor of Neurology
Director, Neurophysiology Laboratories
Director, Neuromuscular Division
Mount Sinai Medical Center
New York, New York




Amy Kontorovich, MD
Medical Director of Adult Cardiovascular Genetics
Assistant Professor of Medicine in Cardiology
Icahn School of Medicine
Mount Sinai Medical Center
New York, New York


Lauren Endriukaitis, PharmD. BCPS
Regulatory and Safety Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois



DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCT

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH, Inc., Advancing Knowledge in Healthcare specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

DISCLOSURE DECLARATION

It is the policy of AKH, Inc., Advancing Knowledge in Healthcare to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH, Inc., Advancing Knowledge in Healthcare prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content, notification of independent and certified CME expectations, referral to National Faculty Initiative training, restriction of topic area or content, restriction to discussion of science only, amendment of content to eliminate discussion of device or technique, use of other faculty for discussion of recommendations, independent review against criteria ensuring evidence support recommendation, moderator review, and peer review.  AKH, Inc., Advancing Knowledge in Healthcare planners and reviewers have no relevant financial relationships to disclose.

Faculty
David Simpson, MD, FAAN has disclosed the following relevant financial relationships:
Consultant - Allergan, Merz
Contracted Research - Allergan, Ipsen, Merz
Speakers Bureau - Allergan, Merz

Lauren Endriukaitis, PharmD, BCPS has disclosed no financial relationships.

Amy Kontorovich, MD, PhD has disclosed the following relevant financial relationships:
Advisory Board – Alnylam Pharmaceuticals

Staff/Reviewers
Louis Settembrino, CHCP, Catalyst Medical Education, LLC, President and CEO: has no financial relationships to disclose.

Dorothy Caputo, MA, BSN, RN, AKH Lead Nurse Planner/Reviewer: has no financial relationships to disclose.

Patricia Brignoni, AKH Director of Operations/Reviewer: has no financial relationships to disclose.

Dorothy A. Duffy, RPh, AKH Pharmacy Reviewer: has no financial relationships to disclose.

Financial support

This activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.

REQUIRED HARDWARE/SOFTWARE

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

Copyright 2020 Catalyst Medical Education, LLC No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.

Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing education for the broad spectrum of health care professionals. This site features a searchable database of accredited Power-Pak C.E.® courses on important topics for today's health care professionals.

PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new courses available on the site.